Pediatric Dose Calculation and Renal Adjustment for an Aminoglycoside
A 4-year-old girl (weight 16 kg, height 100 cm) with febrile neutropenia is to receive gentamicin. Her serum creatinine is 0.5 mg/dL. The team orders gentamicin 2.5 mg/kg IV q8h (conventional dosing). The pharmacy also notes she is receiving piperacillin-tazobactam, and the team asks about once-daily (extended-interval) dosing instead. The institution uses the Schwartz equation for pediatric CrCl: CrCl (mL/min/1.73 m²) = 0.413 × height (cm) / SCr (mg/dL).
1. Calculate the conventional regimen dose and estimate her renal function using the Schwartz equation. Is q8h appropriate?
Read the worked answer
Dose: 2.5 mg/kg × 16 kg = 40 mg per dose IV q8h. Renal function: CrCl = 0.413 × 100 / 0.5 = 82.6 mL/min/1.73 m² - normal for age. Because gentamicin is cleared renally and this child has normal renal function, a conventional q8h interval is acceptable, but note that q8h in children may still produce trough accumulation; many pediatric centers prefer extended-interval dosing. Adjust for actual body weight (16 kg, not ideal) since she is not obese. Verify the dose is within pediatric range (typically 5–7.5 mg/kg/day conventional) - 40 mg q8h = 120 mg/day = 7.5 mg/kg/day, at the upper end; extended-interval is often preferable.
2. Compare conventional vs once-daily (extended-interval) gentamicin for this child, including the pharmacodynamic rationale.
Read the worked answer
Aminoglycosides show concentration-dependent killing and a post-antibiotic effect; peak/MIC ratio drives efficacy while sustained troughs drive nephro/ototoxicity. Extended-interval dosing (e.g., 5–7 mg/kg q24h in children, sometimes q36h) produces a high peak and a low/undetectable trough, maximizing killing and minimizing toxicity. In a child with normal CrCl (~83 mL/min/1.73 m²) and weight 16 kg, an EID dose of ~5–7 mg/kg = 80–112 mg IV q24h is reasonable. Conventional q8h gives lower peaks and higher troughs. Caveats: EID is avoided in pregnancy, endocarditis, and significant renal impairment; monitor a random/trough level before the next dose (target trough <1 mg/L for EID) and consider peak monitoring if MIC is high. Either way, piperacillin-tazobactam provides Gram-negative and anaerobic coverage; gentamicin adds synergy/coverage pending cultures.
3. What monitoring parameters would you set, and how would you interpret a trough of 2.5 mg/L?
Read the worked answer
Monitor: serum creatinine and BUN at baseline and at least every 48–72 h, urine output, daily weight, and gentamicin levels (trough before the 3rd–4th dose; peak 30 min after infusion if indicated). Also monitor for ototoxicity (hearing, balance) and neuromuscular effects. A trough of 2.5 mg/L is elevated (conventional target <2 mg/L; EID target <1 mg/L) and signals accumulation and nephrotoxicity risk. Action: hold the next dose, recheck creatinine (rising SCr = nephrotoxicity), extend the interval (e.g., q12h or q24h) or reduce the dose, and recheck the trough before resuming. Document the change and reassess after renal function stabilizes.